RYAN
XNYS
Market cap5.64bUSD
Nov 20, Last price
47.09USD
1D
1.01%
1Q
8.80%
IPO
64.71%
Name
Ryan Specialty Holdings Inc
Chart & performance
Notes
No notes on this company yet
Write a private note on this company, for your eyes only
Profile
Ryan Specialty Holdings, Inc. functions as a provider of specialized insurance products and comprehensive solutions for the benefit of insurance brokers, agents, and carriers. The company delivers a range of services including distribution, underwriting, product development, administration, and risk management, primarily through its roles as a wholesale broker and a managing underwriter. This firm, established in 2010, maintains its headquarters in Chicago, Illinois.
Key people
Patrick Ryan
Executive Chairman of the Board · since 2024
Jeremiah Bickham
President · since 2024
Stephen Keogh
Co-President, Chief Operating Officer · since 2025
Janice Hamilton
Chief Financial Officer · since 2024
Benjamin Wuller
Chief Executive Officer - Ryan Specialty Underwriting Managers · since 2025
Michael Conklin
Chief Human Resources Officer, Executive Vice President · since 2023
Mark Katz
Executive Vice President, General Counsel, Corporate Secretary · since 2020
Brendan Mulshine
Executive Vice President, Chief Revenue Officer · since 2020
Michael Bungert
Director · since 2025
Nicholas Cortezi
Director · since 2023
Michael O'Halleran
Director · since 2018
Patrick Ryan
Director · since 2024
Timothy Turner
Chief Executive Officer, Director · since 2024
Henry Bienen
Independent Director · since 2012
David Bolger
Independent Director · since 2012
Independent Director · since 2021
Independent Director · since 2023
D. Cameron Findlay
Lead Independent Director · since 2023
Independent Director · since 2023
Independent Director · since 2014
Valuation
Title USD in thousands, except ratios and share amounts | FY | FY | FY | FY | FY | FY | FY |
|---|---|---|---|---|---|---|---|
| 2025‑12 | 2024‑12 | 2023‑12 | 2022‑12 | 2021‑12 | 2020‑12 | 2019‑12 | |
| Income | |||||||
Revenues | |||||||
Cost of revenue | |||||||
Unusual Expense (Income) | |||||||
NOPBT | |||||||
NOPBT Margin | |||||||
Operating Taxes | |||||||
Tax Rate | |||||||
NOPAT | |||||||
Net income | |||||||
Dividends | |||||||
Dividend yield | |||||||
Proceeds from repurchase of equity | |||||||
BB yield | |||||||
| Debt | |||||||
Debt current | |||||||
Long-term debt | |||||||
Deferred revenue | |||||||
Other long-term liabilities | |||||||
Net debt | |||||||
| Cash flow | |||||||
Cash from operating activities | |||||||
CAPEX | |||||||
Cash from investing activities | |||||||
Cash from financing activities | |||||||
FCF | |||||||
| Balance | |||||||
Cash | |||||||
Long term investments | |||||||
Excess cash | |||||||
Stockholders' equity | |||||||
Invested Capital | |||||||
ROIC | |||||||
ROCE | |||||||
| EV | |||||||
Common stock shares outstanding | |||||||
Price | |||||||
Market cap | |||||||
EV | |||||||
EBITDA | |||||||
EV/EBITDA | |||||||
Interest | |||||||
Interest/NOPBT | |||||||